Autoimmune Metaplastic Atrophic Gastritis

Parietal-cell injury reduces gastric acid secretion, while intrinsic-factor autoimmunity can further limit vitamin B12 absorption. The resulting acid deficiency stimulates compensatory hypergastrinemia, meaning increased circulating gastrin. This sequence links immune injury to nutrient deficiency and to enterochromaffin-like cell hyperplasia, providing a mechanistic basis for both hematologic complications and increased gastric neoplasia risk.

Reduced gastric acid can impair the conditions needed for effective iron absorption, so iron deficiency may become clinically important during the disease course. Vitamin B12 deficiency reflects impaired absorption related to loss of intrinsic factor and may develop separately or later. Measuring both nutrients prevents evaluation from focusing only on pernicious anemia and helps identify broader nutritional consequences.

Loss of acid-producing parietal cells removes an important restraint on gastrin production, causing persistent hypergastrinemia. Elevated gastrin is associated with enterochromaffin-like cell hyperplasia, which can accompany the atrophic gastric environment. This cellular response helps explain why evaluation extends beyond nutrient deficiencies and includes surveillance for associated gastric lesions and possible neoplastic change.

Evaluation combines blood tests, antibody assessment, nutrient measurements, and endoscopic biopsy rather than relying on a single finding. Antibodies directed against parietal cells or intrinsic factor can support an autoimmune basis, while nutrient measurements identify iron or vitamin B12 deficiency. These results help clinicians assess complications, guide supplementation, and determine whether gastric tissue assessment is needed.

Endoscopic biopsy provides tissue-level evidence of oxyntic gland atrophy and helps assess associated gastric lesions that blood testing cannot characterize directly. In clinical evaluation, biopsy complements antibody and nutrient results by showing the gastric consequences of the disease. Its findings can therefore support diagnosis and contribute to monitoring for lesions associated with increased gastric neoplasia risk.

Impaired vitamin B12 absorption can progress to pernicious anemia and may also produce neurologic complications. Consequently, clinical assessment should consider both blood-related and neurologic consequences rather than treating anemia as the only outcome. Nutrient measurements help identify deficiency, while the combined clinical and laboratory picture guides supplementation and follow-up for complications linked to prolonged B12 depletion.